MTA family of coregulators in nuclear receptor biology and pathology
- PMID: 18174918
- PMCID: PMC2121320
- DOI: 10.1621/nrs.05010
MTA family of coregulators in nuclear receptor biology and pathology
Abstract
Nuclear receptors (NRs) rely on coregulators (coactivators and corepressors) to modulate the transcription of target genes. By interacting with nucleosome remodeling complexes, NR coactivators potentiate transcription, whereas corepressors inhibit transcription of the target genes. Metastasis-associated proteins (MTA) represent an emerging family of novel NR coregulators. In general, MTA family members form independent nucleosome remodeling and deacetylation (NuRD) complexes and repress the transcription of different genes by recruiting histone deacetylases onto their target genes. However, MTA1 also acts as a coactivator in a promoter-context dependent manner. Recent findings that repression of estrogen receptor transactivation functions by MTA1, MTA1s, and MTA2 and regulation of MTA3 by estrogen signaling have indicated the significance of these proteins in NR signaling. Here, we highlight the action of MTA proteins on NR signaling and their roles in pathophysiological conditions.
Figures


Similar articles
-
Emerging roles of MTA family members in human cancers.Semin Oncol. 2003 Oct;30(5 Suppl 16):30-7. doi: 10.1053/j.seminoncol.2003.08.005. Semin Oncol. 2003. PMID: 14613024 Review.
-
Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.Clin Cancer Res. 2006 Mar 1;12(5):1479-86. doi: 10.1158/1078-0432.CCR-05-1519. Clin Cancer Res. 2006. PMID: 16533771
-
The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.Clin Exp Metastasis. 2009;26(3):215-27. doi: 10.1007/s10585-008-9233-8. Epub 2008 Dec 31. Clin Exp Metastasis. 2009. PMID: 19116762 Review.
-
The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity.J Biol Chem. 2003 Oct 24;278(43):42560-8. doi: 10.1074/jbc.M302955200. Epub 2003 Aug 13. J Biol Chem. 2003. PMID: 12920132
-
Subcellular localization of MTA proteins in normal and cancer cells.Cancer Metastasis Rev. 2014 Dec;33(4):843-56. doi: 10.1007/s10555-014-9511-7. Cancer Metastasis Rev. 2014. PMID: 25398252 Review.
Cited by
-
MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1/MEK3/p38/YB1 axis.Cell Death Dis. 2021 May 6;12(5):451. doi: 10.1038/s41419-021-03729-1. Cell Death Dis. 2021. PMID: 33958583 Free PMC article.
-
Correlation between MTA2 overexpression and tumour progression in esophageal squamous cell carcinoma.Exp Ther Med. 2012 Apr;3(4):745-749. doi: 10.3892/etm.2012.475. Epub 2012 Feb 7. Exp Ther Med. 2012. PMID: 22969963 Free PMC article.
-
Metastasis-associated protein 2 regulates human hepatocellular carcinoma metastasis progression through modulating p38MAPK/MMP2 pathways.J Cancer. 2019 Oct 22;10(26):6716-6725. doi: 10.7150/jca.35626. eCollection 2019. J Cancer. 2019. PMID: 31777601 Free PMC article.
-
Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers: A meta-analysis.Medicine (Baltimore). 2018 Oct;97(41):e12292. doi: 10.1097/MD.0000000000012292. Medicine (Baltimore). 2018. PMID: 30313027 Free PMC article.
-
Mi-2/NuRD complex making inroads into DNA-damage response pathway.Cell Cycle. 2010 Jun 1;9(11):2071-9. doi: 10.4161/cc.9.11.11735. Epub 2010 Jun 1. Cell Cycle. 2010. PMID: 20505336 Free PMC article. Review.
References
-
- Ahringer J. NuRD and SIN3 histone deacetylase complexes in development. Trends Genet. 2000;16:351–6. - PubMed
-
- Bagheri-Yarmand R., Talukder A. H., Wang R. A., Vadlamudi R. K., Kumar R. Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis. Development. 2004;131:3469–79. - PubMed
-
- Balasenthil S., Broaddus R. R., Kumar R. Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. Hum Pathol. 2006;37:656–61. - PubMed
-
- Balasenthil S., Gururaj A. E., Talukder A. H., Bagheri-Yarmand R., Arrington T., Haas B. J., Braisted J. C., Kim I., Lee N. H., Kumar R. Identification of Pax5 as a target of MTA1 in B-cell lymphomas. Cancer Res. 2007;67:7132–8. - PubMed
-
- Bowen N. J., Fujita N., Kajita M., Wade P. A. Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys Acta. 2004;1677:52–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous